Amicus Therapeutics, Inc
FOLD
$0.00
+0.21%
FOLD price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Amicus Therapeutics, Inc's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
2 analysts
Implied Upside
—
vs. current price
Analyst Count
2
covering this stock
Price Range
$0 - $0
Analyst target range
FOLD Technical Analysis
Beta
0.48
0.48x market volatility
Max Drawdown
-35.1%
Largest decline past year
52-Week Range
$6-$15
Price range past year
Annual Return
+101.3%
Cumulative gain past year
| Period | FOLD Return | S&P 500 |
|---|---|---|
| 1m | +0.4% | +12.8% |
| 3m | +1.5% | +2.8% |
| 6m | +67.1% | +4.0% |
| 1y | +101.3% | +29.9% |
| ytd | +1.5% | +4.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is FOLD Overvalued?
PE
-162.0x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
86.6x
Enterprise Value Multiple